Market Research Logo

U.S. Uterine Fibroid Market Research Report - Forecast to 2022

U.S. Uterine Fibroid Market Research Report - Forecast to 2022

Introduction
Uterine Fibroids are the abnormal growth that gets developed inside or on the wall of a woman’s uterus. These are also known as leiomyoma or myomas. These are noncancerous growths that cause symptoms such as heavy bleeding between or during the menstrual cycle, pain in pelvis or lower back, increased menstrual cramping, swelling enlargement of the abdomen. Increasing prevalence due to heredity and rising number of treatments to cure this disease has fuelled the growth of this market.
U.S. Uterine Fibroid Market has been segmented on the basis of type which comprises of Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others. On the basis of diagnosis the market is segmented into Medical Resonance Imaging (MRI) scanners, Computed tomography (CT), Ultrasounds and others. On the basis of treatment the market is segmented into Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy.
The U.S. Market for Uterine Fibroids is expected to reach USD 39,993.2 million by the end of the forecasted period and is expected to grow at a CAGR of 3.24%.

Key Players
Some of the key players in this market are: AstraZeneca (England), Cook Medical Inc. (US), Boston Scientific Corporation (US), GE Healthcare (U.K.), AbbVie Inc. (U.S.), Hologic (U.S.), and others.
Study Objectives:
Ø To provide insights about factors, influencing and affecting the market growth.
Ø To provide historically and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries.
Ø To provide historical and forecast revenue of the market segments based on types, diagnosis, and treatment.
Ø To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market.

Target Audience
• Uterine Fibroid Devices and Drug Manufacturers
• Uterine Fibroid Devices and Drug Suppliers
• Private Research Laboratories
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Medical Research Laboratories

Key Finding
• The U.S. Uterine Fibroid market and is expected to reach USD 39,993.2 million by 2022.
• By Type, Intramural Fibroids holds the largest market share of U.S. uterine fibroid market and is expected to reach USD 14,972.5 million by 2022.
• By Treatment, hysterectomy holds the largest market share of U.S. uterine fibroid market and is expected to reach USD 8,042.3 million by 2022.

The reports also cover country level analysis:
America
• North America
Europe
Western Europe
• Germany
• France
• Italy
• Spain
• UK
• Rest of Western Europe
• Eastern Europe
Asia
• China
• India
• Japan
• South Korea
• Rest of Asia
Middle East & Africa


1 Introduction
1.1.1 Prevalence of the Uterine Fibroids in U.S.
2 Scope of Study
2.1 Research Objective
2.2 Assumptions & Limitations
2.2.1 Assumptions
2.2.2 Limitations
2.3 Market Structure
3 Research Methodology
3.1 Primary Research
3.2 Secondary Research
4 U.S. Uterine Fibroid Market
4.1 Introduction
4.2 U.S. Uterine Fibroid Market, By Type
4.3 U.S. Uterine Fibroid Market, By Diagnosis
4.4 U.S. Uterine Fibroid Market, By Treatment
5 Company Profile
5.1 AstraZeneca
5.1.1 Company Overview
5.1.2 Product overview
5.1.3 Financial Overview
5.1.4 Key Development
5.1.5 SWOT Analysis
5.2 Cook Medical Inc.
5.2.1 Overview
5.2.2 Product Overview
5.2.3 Financials
5.2.4 Key Developments
5.2.5 SWOT Analysis
5.3 Boston Scientific Corporation
5.3.1 Company Overview
5.3.2 Product/Business Segment Overview
5.3.3 Financial Overview
5.3.4 Key Development
5.3.1 SWOT Analysis
5.4 GE Healthcare
5.4.1 Company Overview
5.4.2 Product/Business Segment Overview
5.4.3 Financial Overview
5.4.4 Key Development
5.4.5 SWOT Analysis
5.5 AbbVie Inc.
5.5.1 Company Overview
5.5.2 Product/Business Segment Overview
5.5.3 Financial Overview
5.5.4 Key Development
5.5.5 SWOT Analysis
5.6 Hologic, Inc.
5.6.1 Company Overview
5.6.2 Product/Business Segment Overview
5.6.3 Financial Overview
5.6.4 Key Development
5.6.5 SWOT Analysis
List of Tables:
TABLE 1 U.S. UTERINE FIBROID MARKET, BY TYPE, 2013-2022 (USD MILLION)
TABLE 2 U.S. UTERINE FIBROID MARKET, BY DIAGNOSIS, 2013-2022 (USD MILLION)
TABLE 3 U.S. UTERINE FIBROID MARKET, BY TREATMENT, 2013-2022 (USD MILLION)
TABLE 4 U.S. UTERINE FIBROID MARKET, BY TREATMENT TYPE, 2013-2022 (USD MILLION)
TABLE 5 PIPELINE PRODUCTS FOR UTERINE FIBROIDS
TABLE 6 ASTRAZENECA: KEY DEVELOPMENT
TABLE 7 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENT
TABLE 8 GE HEALTHCARE: KEY DEVELOPMENT
TABLE 9 ABBVIE INC.: KEY DEVELOPMENT
TABLE 10 HOLOGIC INC.: KEY DEVELOPMENT
List of Figures:
FIGURE 1 COMPARISON BETWEEN DIAGNOSIS & TREATMENT MARKET, 2013-2022 (USD MILLION)
FIGURE 2 U.S. UTERINE FIBROID MARKET: MARKET STRUCTURE
FIGURE 3 RESEARCH PROCESS
FIGURE 4 U.S. UTERINE FIBROID MARKET, BY TYPE, 2015 & 2022 (USD MILLION)
FIGURE 5 U.S. UTERINE FIBROID MARKET, BY DIAGNOSIS, 2015 & 2022 (USD MILLION)
FIGURE 6 TREATMENTS FOR UTERINE FIBROIDS
FIGURE 7 U.S. UTERINE FIBROID MARKET, BY TREATMENT, 2013-2022 (USD MILLION)
FIGURE 8 U.S. UTERINE FIBROID MARKET, BY TREATMENT TYPE, 2015 & 2022 (USD MILLION)
FIGURE 9 PHARMACOTHERAPY TREATMENT FORECAST, 2015-2022
FIGURE 10 ASTRAZENECA: RECENT FINANCIAL
FIGURE 11 ASTRAZENECA: GEOGRAPHICAL MIX
FIGURE 12 ASTRAZENECA: OPERATING SEGMENTS
FIGURE 13 ASTRAZENECA: SWOT ANALYSIS
FIGURE 14 BOSTON SCIENTIFIC CORPORATION: RECENT FINANCIAL
FIGURE 15 BOSTON SCIENTIFIC CORPORATION: RECENT FINANCIAL
FIGURE 16 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS
FIGURE 17 GE HEALTHCARE: RECENT FINANCIAL
FIGURE 18 GE HEALTHCARE: GEOGRAPHICAL MIX
FIGURE 19 GE HEALTHCARE: OPERATING SEGMENTS
FIGURE 20 GE HEALTHCARE: SWOT ANALYSIS
FIGURE 21 ABBVIE INC.: RECENT FINANCIAL
FIGURE 22 ABBVIE INC.: GEOGRAPHICAL MIX
FIGURE 23 ABBVIE INC: OPERATING SEGMENTS
FIGURE 24 ABBVIE INC.: SWOT ANALYSIS
FIGURE 25 HOLOGIC INC.: RECENT FINANCIAL
FIGURE 26 HOLOGIC INC: GEOGRAPHICAL MIX
FIGURE 27 HOLOGIC INC: OPERATING SEGMENTS
FIGURE 28 HOLOGIC INC.: SWOT ANALYSIS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report